Side-by-side comparison of AI visibility scores, market position, and capabilities
Paris CAC 40 luxury group (Euronext: KER) owning Gucci/Saint Laurent/Bottega Veneta/Balenciaga; new CEO Luca de Meo (Sep 2025) tasked with Gucci revenue recovery competing with LVMH for ultra-luxury market share.
Kering S.A. is a Paris, France-based global luxury goods group — publicly traded on Euronext Paris (EPA: KER) as a CAC 40 component — owning and operating a portfolio of iconic luxury fashion, leather goods, jewelry, and eyewear houses including Gucci, Saint Laurent, Bottega Veneta, Balenciaga, Alexander McQueen, Brioni, Boucheron, Pomellato, DoDo, Qeelin, and Kering Eyewear through approximately 47,000 employees and 1,813 directly operated stores worldwide. Founded in 1962 by François Pinault as a timber and building materials trading company, Kering (formerly Pinault-Printemps-Redoute, then PPR) transformed into a luxury group through landmark acquisitions: Gucci Group in 1999 ($3 billion, acquiring Gucci, Saint Laurent, Bottega Veneta, Balenciaga, and Alexander McQueen), rebranding from PPR to Kering in 2013 to signal the luxury focus. François-Henri Pinault (François's son) served as Chairman and CEO for nearly two decades before Luca de Meo was appointed CEO in September 2025 — with François-Henri remaining as Executive Chairman. Kering generates approximately €17-20 billion in annual revenue, with Gucci historically accounting for approximately 50% of group revenue.
Cloud Veterinary Practice Management & Client Engagement
Cloud vet practice management acquired by IDEXX; Auckland New Zealand; 5,000+ clinics in US, Australia, NZ, and UK; covers patient check-in through invoicing and end-of-day reconciliation.
ezyVet is a cloud-based veterinary practice management and client engagement platform that provides veterinary clinics with patient records, scheduling, invoicing, billing, client communication, and analytics in a fully browser-based system, headquartered in Auckland, New Zealand and acquired by IDEXX Laboratories — the global veterinary diagnostics leader — in 2021 to extend IDEXX's software platform capabilities alongside its diagnostic products. ezyVet serves more than 5,000 veterinary clinics globally with particular strength in the United States, Australia, New Zealand, and the United Kingdom.\n\nezyVet's platform provides a comprehensive clinical workflow covering patient check-in, consultation and treatment planning, prescription management, invoicing, and end-of-day reconciliation. The two-way client communication features include automated appointment reminders via SMS and email, post-visit summaries, and a client portal where pet owners can access records and request appointments. Deep integration with IDEXX's diagnostic products — including in-clinic analyzers, reference laboratory services, and imaging systems — allows results to flow directly into patient records, providing a significant competitive advantage now that IDEXX owns the platform.\n\nAs an IDEXX-owned platform, ezyVet benefits from IDEXX's global distribution network, integration with IDEXX's full diagnostics portfolio, and the ability to bundle software with diagnostic equipment and service agreements. ezyVet competes with Provet Cloud, Vetspire, Digitail, and the legacy IDEXX Cornerstone platform in the veterinary software market. IDEXX's ownership creates both an advantage (deep diagnostics integration) and a competitive consideration for clinics that use non-IDEXX diagnostic products.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.